Patients with lung cancer have higher breath temperature
the ONA take:
According to new research presented at the European Respiratory Society (ERS) International Congress in Munich, Germany, testing the temperature of breath may be an easy method to diagnose patients with lung cancer. In the study, researchers identified 82 patients to receive a breath temperature test after an x-ray examination suggested a diagnosis of lung cancer.
Researchers measured the patients' breath using an X-Halo device, a thermometer for breath. The X-Halo device confirmed lung cancer in 40 patients and rejected the diagnosis in 42 patients.
The researchers found that the patients with lung cancer had an increased breath temperature compared with those without lung cancer. In addition, the temperature rose with their lung cancer stage and the duration in which a patient had smoked. The researchers were also able to identify the cut-off temperature for which lung cancer could be proven accurately.
Researchers hope that they can refine this test to be used to diagnose patients with lung cancer by measuring their breath temperature. They suggest that the test would be simple, cheap, and noninvasive.
Testing the temperature of breath may be an easy method to diagnose patients with lung cancer.
The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today (8 September 2013), suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of lung cancer.
Many research teams have been looking at the possibility of using breath tests for a number of cancers. This is the first study looking at breath temperature as a marker in lung cancer.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|